Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
$11.1M Sell
169,630
-1,435
-0.8% -$90.2K 0.08% 92
2016
Q4
$10.7M Buy
171,065
+102
+0.1% +$6.23K 0.08% 91
2016
Q3
$10.8M Sell
170,963
-597
-0.3% -$38.6K 0.09% 90
2016
Q2
$10.6M Buy
171,560
+1,284
+0.8% +$78.2K 0.1% 93
2016
Q1
$9.73M Sell
170,276
-2,811
-2% -$157K 0.1% 93
2015
Q4
$10.3M Sell
173,087
-4,529
-3% -$261K 0.11% 95
2015
Q3
$9.66M Buy
177,616
+4,891
+3% +$318K 0.11% 91
2015
Q2
$11.6M Sell
172,725
-75,036
-30% -$4.9M 0.13% 77
2015
Q1
$14.5M Buy
247,761
+1,822
+0.7% +$110K 0.17% 68
2014
Q4
$16.1M Sell
245,939
-4,922
-2% -$310K 0.2% 60
2014
Q3
$14.5M Buy
250,861
+21,706
+9% +$1.21M 0.2% 63
2014
Q2
$12.9M Sell
229,155
-2,238
-1% -$117K 0.19% 69
2014
Q1
$11.9M Buy
231,393
+36,032
+18% +$1.82M 0.19% 72
2013
Q4
$10.3M Sell
195,361
-42
-0% -$2.06K 0.17% 78
2013
Q3
$8.74M Buy
195,403
+3,954
+2% +$175K 0.16% 78
2013
Q2
$7.92M Buy
+191,449
New +$8.37M 0.17% 75

Other funds holding ABBV

TIAA CREF Trust's ABBV Position: Q1 2017 in Review

TIAA CREF Trust reduced its AbbVie (ABBV) stake by 0.84% in Q1 2017, selling an estimated $90.2K and leaving 169,630 shares worth $11.1M. The position accounts for 0.08% of the portfolio, ranked #92.

TIAA CREF Trust first reported a position in ABBV in Q2 2013 and has held it in 16 quarters since. The position peaked at $16.1M in Q4 2014. 1,727 funds tracked by Wall St. Rank hold ABBV as of Q1 2017.

  • TIAA CREF Trust held 169,630 shares of AbbVie worth $11.1M as of Q1 2017.
  • TIAA CREF Trust sold 1,435 AbbVie shares in Q1 2017, an estimated $90.2K.
  • AbbVie made up 0.08% of TIAA CREF Trust's portfolio in Q1 2017, its #92 holding.
  • TIAA CREF Trust first reported a position in AbbVie in Q2 2013 and has held it in 16 quarters since.
  • TIAA CREF Trust's AbbVie position peaked at $16.1M in Q4 2014.
  • 1,727 funds tracked by Wall St. Rank held AbbVie as of Q1 2017.

Based on TIAA CREF Trust's 13F filing for Q1 2017, filed 3 May 2017.